© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
April 13, 2018
Unique considerations are called for when caring for intravenous drug users with newly diagnosed HIV/HCV coinfections.
Investigating RBX2660 for Recurrent C Difficile Infection
Examining Oral Vancomycin as a First-Line CDI Therapy
The Latest on Monkeypox
Assessing Vancomycin and Metronidazole Susceptibility for CDI